{
    "code": "01048422",
    "time": "2015-06-25 05:22:20",
    "許可證字號": "衛署藥製字第048422號",
    "註銷狀態": "已註銷",
    "註銷日期": "101\/03\/20",
    "註銷理由": "自請註銷",
    "有效日期": "100\/11\/28",
    "發證日期": "95\/11\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104842201",
    "中文品名": "\"溫士頓\" 治眩寧錠",
    "英文品名": "Slonlin Tablets \"Winston\"",
    "適應症": "梅尼爾氏症候群所引起之暈眩、聽力障礙。",
    "劑型": "110錠劑",
    "包裝": "4-1000錠塑膠瓶裝 4-1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "BETAHISTINE DIHYDROCHLORIDE",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1217820200  溫士頓醫藥股份有限公司",
    "申請商地址": "台南市永康區鹽洲里仁愛街１１７號",
    "主製造廠": {
        "製造廠名稱": "1217820300  溫士頓醫藥股份有限公司",
        "製造廠廠址": "臺南市永康區鹽洲里仁愛街一一七號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412000310",
            "成分名稱": "BETAHISTINE DIHYDROCHLORIDE",
            "含量描述": "",
            "含量": "16.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 010484220001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=01048422&Seq=001&Type=9"
        },
        {
            "title": "外盒 010484220003.jpg 010484220002.jpg 010484220001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=01048422&Seq=003&Type=8"
        }
    ]
}